Cargando…
The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia
Sirtuin deacetylases regulate diverse cellular pathways and influence disease processes. Our previous studies identified the brain-enriched sirtuin-2 (SIRT2) deacetylase as a potential drug target to counteract neurodegeneration. In the present study, we characterize SIRT2 inhibition activity of the...
Autores principales: | Chen, Xiqun, Wales, Pauline, Quinti, Luisa, Zuo, Fuxing, Moniot, Sébastien, Herisson, Fanny, Rauf, Nazifa Abdul, Wang, Hua, Silverman, Richard B., Ayata, Cenk, Maxwell, Michelle M., Steegborn, Clemens, Schwarzschild, Michael A., Outeiro, Tiago F., Kazantsev, Aleksey G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301865/ https://www.ncbi.nlm.nih.gov/pubmed/25608039 http://dx.doi.org/10.1371/journal.pone.0116919 |
Ejemplares similares
-
Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia
por: Spires-Jones, Tara L., et al.
Publicado: (2012) -
Editorial on Special Topic: Sirtuins in Metabolism, Aging, and Disease
por: Kazantsev, Aleksey G., et al.
Publicado: (2012) -
Structures, Substrates, and Regulators of Mammalian Sirtuins – Opportunities and Challenges for Drug Development
por: Moniot, Sébastien, et al.
Publicado: (2012) -
Structure-based development of novel sirtuin inhibitors
por: Schlicker, Christine, et al.
Publicado: (2011) -
Highlights of the Keystone Symposium: sirtuins in metabolism, aging and disease
por: Maxwell, Michele M, et al.
Publicado: (2012)